Imiquimod

Imiquimod
Clinical data
Trade names	Aldara, others
Other names	1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
AHFS/Drugs.com	Monograph
MedlinePlus	a698010
License data	EU EMA: by INN; US DailyMed: Imiquimod;
Pregnancy; category	AU: B1;
Routes of; administration	Topical
ATC code	D06BB10 (WHO) ;
Legal status
Legal status	UK: POM (Prescription only); US: WARNINGRx-only; EU: Rx-only;
Pharmacokinetic data
Elimination half-life	30 hours (topical dose), 2 hours (subcutaneous dose)
Identifiers
	IUPAC name 3-(2-Methylpropyl)-3,5,8-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,7,10,12-hexaen-7-amine;
CAS Number	99011-02-6 ;
PubChem CID	57469;
IUPHAR/BPS	5003;
DrugBank	DB00724 ;
ChemSpider	51809 ;
UNII	P1QW714R7M;
KEGG	D02500 ;
ChEBI	CHEBI:36704 ;
ChEMBL	ChEMBL1282 ;
CompTox Dashboard (EPA)	DTXSID7041047 ;
ECHA InfoCard	100.131.047
Chemical and physical data
Formula	C14H16N4
Molar mass	240.310 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES n3c1ccccc1c2c(ncn2CC(C)C)c3N;
	InChI InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17) ; Key:DOUYETYNHWVLEO-UHFFFAOYSA-N ;
	(verify)

Imiquimod, sold under the brand name Aldara among others, is a medication that acts as an immune response modifier that is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis.

Scientists at 3M's pharmaceuticals division discovered the drug and 3M obtained the first FDA approval in 1997. As of 2015, imiquimod is generic and is available worldwide under many brands. In 2021, it was the 290th most commonly prescribed medication in the United States, with more than 600,000 prescriptions.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.